Search
davunetide
Mechanism of action:
- promotes microtubule stability
- reduces tau phosphorylation
Clinical trials:
- davunetide is not effective for treatment of prgressive supranuclear palsy
General
peptide
neurologic agent
Database Correlations
PUBCHEM correlations
References
- Boxer AL et al.
Davunetide in patients with progressive supranuclear palsy:
A randomised, double-blind, placebo-controlled phase 2/3 trial.
Lancet Neurol 2014 Jul; 13:676
PMID: 24873720
http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(14)70088-2/fulltext